182 related articles for article (PubMed ID: 28181563)
1. The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria.
Roussilhon C; Bang G; Bastaert F; Solhonne B; Garcia-Verdugo I; Peronet R; Druilhe P; Sakuntabhai A; Mecheri S; Sallenave JM
Sci Rep; 2017 Feb; 7():42243. PubMed ID: 28181563
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
[TBL] [Abstract][Full Text] [Related]
3. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.
Francischetti IM; Oliveira CJ; Ostera GR; Yager SB; Debierre-Grockiego F; Carregaro V; Jaramillo-Gutierrez G; Hume JC; Jiang L; Moretz SE; Lin CK; Ribeiro JM; Long CA; Vickers BK; Schwarz RT; Seydel KB; Iacobelli M; Ackerman HC; Srinivasan P; Gomes RB; Wang X; Monteiro RQ; Kotsyfakis M; Sá-Nunes A; Waisberg M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):786-98. PubMed ID: 22116094
[TBL] [Abstract][Full Text] [Related]
4. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
6. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
7. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria.
Kobbe R; Schreiber N; May J; Jacobs T
Antimicrob Agents Chemother; 2008 Apr; 52(4):1583-4. PubMed ID: 18268089
[No Abstract] [Full Text] [Related]
9. The monoterpene 1,8-cineole prevents cerebral edema in a murine model of severe malaria.
Santos ECD; Silva LS; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
PLoS One; 2022; 17(5):e0268347. PubMed ID: 35550638
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.
Reis PA; Comim CM; Hermani F; Silva B; Barichello T; Portella AC; Gomes FC; Sab IM; Frutuoso VS; Oliveira MF; Bozza PT; Bozza FA; Dal-Pizzol F; Zimmerman GA; Quevedo J; Castro-Faria-Neto HC
PLoS Pathog; 2010 Jun; 6(6):e1000963. PubMed ID: 20585569
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.
Liu M; Solomon W; Cespedes JC; Wilson NO; Ford B; Stiles JK
J Neuroinflammation; 2018 Apr; 15(1):104. PubMed ID: 29636063
[TBL] [Abstract][Full Text] [Related]
13. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
14. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
Singh RP; Kashiwamura S; Rao P; Okamura H; Mukherjee A; Chauhan VS
J Immunol; 2002 May; 168(9):4674-81. PubMed ID: 11971017
[TBL] [Abstract][Full Text] [Related]
15. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
16. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
[TBL] [Abstract][Full Text] [Related]
18. In vitro culture of Plasmodium berghei-ANKA maintains infectivity of mouse erythrocytes inducing cerebral malaria.
Jambou R; El-Assaad F; Combes V; Grau GE
Malar J; 2011 Nov; 10():346. PubMed ID: 22118493
[TBL] [Abstract][Full Text] [Related]
19. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
20. Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL/6 mice.
Cariaco Y; Lima WR; Sousa R; Nascimento LAC; Briceño MP; Fotoran WL; Wunderlich G; Dos Santos JL; Silva NM
Sci Rep; 2018 Jan; 8(1):1547. PubMed ID: 29367729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]